Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor

Saved in:
Bibliographic Details
Published inFrontiers in Pharmacology Vol. 10
Main Authors Te-Ling Lu, Wei-Ting Chang, Chee-Hong Chan, Sheng-Nan Wu
Format Journal Article
LanguageJapanese
Published Frontiers Media SA 18.02.2019
Subjects
delayed-rectifier K+ current
erg-mediated K+ current
M-type K+ current
membrane potential
Pharmacology
pituitary cell
RM1-950
Therapeutics. Pharmacology
tolvaptan
Online AccessGet full text
ISSN1663-9812
DOI10.3389/fphar.2019.00076

Cover

More Information
ISSN:1663-9812
DOI:10.3389/fphar.2019.00076